Gene · 730249
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis. | Int J Epidemiol | 2023 | 36913255 | PubTator, text mining | PubMed |
| A phylogenomic analysis of Limosilactobacillus reuteri reveals ancient and stable evolutionary relationships with rodents and birds and zoonotic transmission to humans. | BMC Biol | 2023 | 36907868 | PubTator, text mining | PubMed |
| Bench-to-Bedside Studies of Arginine Deprivation in Cancer. | Molecules | 2023 | 36903394 | PubTator, text mining | PubMed |
| Novel long non-coding RNAs associated with inflammation and macrophage activation in human. | Sci Rep | 2023 | 36899011 | PubTator, text mining | PubMed |
| Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways. | Cell Biosci | 2023 | 36882813 | PubTator, text mining | PubMed |
| Exosomal RNAs in the development and treatment of pituitary adenomas. | Front Endocrinol (Lausanne) | 2023 | 36875488 | PubTator, text mining | PubMed |
| 4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING. | Cell Rep | 2023 | 36862550 | PubTator, text mining | PubMed |
| Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. | Front Immunol | 2023 | 36860847 | PubTator, text mining | PubMed |
| Immunometabolic Signature during Respiratory Viral Infection: A Potential Target for Host-Directed Therapies. | Viruses | 2023 | 36851739 | PubTator, text mining | PubMed |
| The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. | Int J Mol Sci | 2023 | 36835628 | PubTator, text mining | PubMed |
| Healthy and Osteoarthritis-Affected Joints Facing the Cellular Crosstalk. | Int J Mol Sci | 2023 | 36835530 | PubTator, text mining | PubMed |
| Itaconate Suppresses the Activation of Mitochondrial NLRP3 Inflammasome and Oxidative Stress in Allergic Airway Inflammation. | Antioxidants (Basel) | 2023 | 36830047 | PubTator, text mining | PubMed |
| Obesity hormones and itaconate mediating inflammation in human colon cancer cells - Another lead to early-onset colon cancer? | Heliyon | 2023 | 36825172 | PubTator, text mining | PubMed |
| Mitochondrial Cristae Morphology Reflecting Metabolism, Superoxide Formation, Redox Homeostasis, and Pathology. | Antioxid Redox Signal | 2023 | 36793196 | PubTator, text mining | PubMed |
| Comparative transcriptome analysis of Saposhnikovia divaricata to reveal drought and rehydration adaption strategies. | Mol Biol Rep | 2023 | 36781610 | PubTator, text mining | PubMed |
| Increased fatty acid metabolism and decreased glycolysis are hallmarks of metabolic reprogramming within microglia in degenerating white matter during recovery from experimental stroke. | J Cereb Blood Flow Metab | 2023 | 36772984 | PubTator, text mining | PubMed |
| Cepharanthine Alleviates DSS-Induced Ulcerative Colitis via Regulating Aconitate Decarboxylase 1 Expression and Macrophage Infiltration. | Molecules | 2023 | 36770726 | PubTator, text mining | PubMed |
| BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. | Int J Mol Sci | 2023 | 36769189 | PubTator, text mining | PubMed |
| Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36769056 | PubTator, text mining | PubMed |
| The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. | Int J Mol Sci | 2023 | 36768977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/730249/papers?page=21